Table 1

Patient demographics and history of diabetes by treatment group

Treatment group
Placebo
0.1 mg NBI-60240.5 mg NBI-60241.0 mg NBI-6024
n50484347
Age (years)17.9 ± 6.317.4 ± 6.417.9 ± 6.418.7 ± 7.1
Sex
    Male31263031
    Female19221316
Peak C-peptide baseline (pmol/ml)1.36 ± 0.631.35 ± 0.631.41 ± 0.631.42 ± 0.61
A1C baseline (%)7.9 ± 1.67.8 ± 1.68.1 ± 2.08.1 ± 2.0
Daily insulin dose (IU)31.3 ± 19.433.1 ± 15.830.5 ± 11.932.1 ± 14.9
Time since symptoms (months)2.1 ± 1.12.1 ± 1.42.1 ± 1.12.3 ± 1.9
Time since diagnosis (months)1.2 ± 0.51.2 ± 0.71.2 ± 0.71.2 ± 0.8
  • Data are means ± SD or n.